HealthCare Royalty Partners

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$115.0M
total disclosed, rounds participated
Stages
—

Portfolio · 1

RedHill Biopharma
Proprietary Drugs for Gastrointestinal and Infectious Diseases
1 round $115.0M committed Latest: 2020-02

Investment activity

Portfolio by sector

Health Tech & Life Sciences1

Q&A

What is HealthCare Royalty Partners' primary investment focus?
HealthCare Royalty Partners focuses on the Health Tech & Life Sciences sector, with one portfolio company, RedHill Biopharma, in this area.
Can you name a notable portfolio company of HealthCare Royalty Partners?
RedHill Biopharma, a company developing proprietary drugs for gastrointestinal and infectious diseases, is a portfolio company of HealthCare Royalty Partners.
What type of funding rounds does HealthCare Royalty Partners typically participate in?
HealthCare Royalty Partners has participated in Debt Financing rounds.
When was HealthCare Royalty Partners' most recent investment activity?
HealthCare Royalty Partners' most recent investment activity occurred in February 2020.
What is the typical investment range for HealthCare Royalty Partners?
HealthCare Royalty Partners' investment range is between $115M and $115M.